Implementing a Provisional Supply Chain to Guarantee Availability of Contraceptives at the Community Level
Following the events of March 2, 2012, in Mali, the US Agency for International Development (USAID) suspended its direct support to the Malian government, particularly for contraceptives. This suspension negatively affected the availability of contraceptives at medicine sales outlets in community health centers (centres de santé communautaire; CSCom) throughout the country. USAID’s implementing partners are [...]
Integration of Community Health Workers in Mali’s Essential Medicines Information and Logistics Management System
The Direction de la Pharmacie et du Médicament (DPM; Directorate of Pharmacy and Medicines), with technical and financial support provided by the Systems for Improved Access to Ph armaceuticals and Services (SIAPS) Program, organized a workshop at the Hotel Club de Sélingué, March 11–15, 2013, to develop a standard operating procedures (SOP) manual for the logistics [...]
Rapid Evaluation, Rapid Solutions: First End Use Verification Survey in Guinea
The baseline EUV survey evaluated malaria drug management and treatment practices in 25 facilities. The End Use Verification (EUV) survey is a routine assessment of the supply chain of malaria medicines/products and of the diagnosis and treatment of malaria at the health facility level. EUV surveys are typically conducted more than once per year in [...]
An Interview With An XDR-TB Survivor
It all began in November 2001 for Mildred Fernando when she was diagnosed with tuberculosis (TB) – a preventable and curable disease which caused the death of 1.4 million people in 2011. She was only 19 years old, working on completing her last semester in college when she contracted TB from her father who sadly [...]
Decreasing the Burden of TB Through Collaboration and Streamlined Approaches
The state of tuberculosis (TB) is in a tug-of-war as current challenges threaten to undo past successes. One of the primary hurdles currently facing TB prevention and cure is the emergence of strains that are resistant to at least two of the most effective medicines (rifampicin and isoniazid). So-called drug-resistant (DR)-TB arises when patients are [...]
Financing New Diagnostics for TB
Although tuberculosis (TB) has existed for thousands of years, new tools for diagnosing and treating it are quickly changing the way in which countries plan TB care and treatment programs. The National Tuberculosis Programs (NTPs) in most low-income countries depend heavily on international donor funding. With recent declines in foreign assistance, however, increased awareness about [...]
Connect with Us
